CTCs isolated from breast cancer patients demonstrate an altered apoptotic pathway [91,92], and FSS exposed breast cancer cells decrease the abundance of pro-apoptotic proteins such as caspase 3 [29,52]. This evidence concerns the gene CASP3 and breast cancer.